Preseasonal treatment with omalizumab prevents fall asthma exacerbations
Temporarily adding omalizumab to the standard care for asthma reduces fall asthma exacerbations in inner-city youth. That is the conclusion of a group of paediatricians who published a paper in the Journal of Allergy and Clinical Immunology. The beneficial effect was most notable in children who had recently experienced an exacerbation. Continue reading